참고문헌
- Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 2013;45:1176-82. https://doi.org/10.1038/ng.2744
- World Health Organization. Global tuberculosis report 2021 [Internet]. Geneva: World Health Organization; 2021 [cited 2023 Feb 9]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.
- Furin J, Cox H, Pai M. Tuberculosis. Lancet 2019;393:1642-56. https://doi.org/10.1016/S0140-6736(19)30308-3
- Simmons JD, Stein CM, Seshadri C, Campo M, Alter G, Fortune S, et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol 2018;18:575-89. https://doi.org/10.1038/s41577-018-0025-3
- Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med 2015;372:2127-35. https://doi.org/10.1056/NEJMra1405427
- Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009;33:956-73. https://doi.org/10.1183/09031936.00120908
- Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016;13:e1002152.
- Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999;282:677-86. https://doi.org/10.1001/jama.282.7.677
- Esmail H, Barry CE, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci 2014;369:20130437.
- Esmail H, Lai RP, Lesosky M, Wilkinson KA, Graham CM, Coussens AK, et al. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography. Nat Med 2016;22:1090-3. https://doi.org/10.1038/nm.4161
- Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev 2018;31:e00021-18.
- Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers 2016;2:16076.
- Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. J Immunol 2010;185:15-22. https://doi.org/10.4049/jimmunol.0903856
- Lau A, Lin C, Barrie J, Winter C, Armstrong G, Egedahl ML, et al. The radiographic and mycobacteriologic correlates of subclinical pulmonary TB in Canada: a retrospective cohort study. Chest 2022;162:309-20. https://doi.org/10.1016/j.chest.2022.01.047
- Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009;7:845-55. https://doi.org/10.1038/nrmicro2236
- World Health Organization. Development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease [Internet]. Geneva: World Health Organization; 2017 [cited 2023 Feb 9]. Available from: https://apps.who.int/iris/handle/10665/259176.
- Getahun H, Matteelli A, Abubakar I, Hauer B, Pontali E, Migliori GB. Advancing global programmatic management of latent tuberculosis infection for at risk populations. Eur Respir J 2016;47:1327-30. https://doi.org/10.1183/13993003.00449-2016
- Schumacher SG, Denkinger CM. Diagnostic test for incipient tuberculosis: a step forward, many more to go. Am J Respir Crit Care Med 2018;197:1106-7. https://doi.org/10.1164/rccm.201803-0469ED
- Nikolova M, Markova R, Drenska R, Muhtarova M, Todorova Y, Dimitrov V, et al. Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis 2013;75:277-81. https://doi.org/10.1016/j.diagmicrobio.2012.11.023
- Halliday A, Whitworth H, Kottoor SH, Niazi U, Menzies S, Kunst H, et al. Stratification of latent Mycobacterium tuberculosis infection by cellular immune profiling. J Infect Dis 2017;215:1480-7. https://doi.org/10.1093/infdis/jix107
- Mpande CA, Musvosvi M, Rozot V, Mosito B, Reid TD, Schreuder C, et al. Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection. Am J Respir Crit Care Med 2021;203:1556-65. https://doi.org/10.1164/rccm.202007-2686OC
- Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J 2016;48:1751-63. https://doi.org/10.1183/13993003.01012-2016
- Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 2016;387:2312-22. https://doi.org/10.1016/S0140-6736(15)01316-1
- Suliman S, Thompson EG, Sutherland J, Weiner J, Ota MO, Shankar S, et al. Four-gene pan-African blood signature predicts progression to tuberculosis. Am J Respir Crit Care Med 2018;197:1198-208. https://doi.org/10.1164/rccm.201711-2340OC
- Gupta RK, Turner CT, Venturini C, Esmail H, Rangaka MX, Copas A, et al. Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis. Lancet Respir Med 2020;8:395-406. https://doi.org/10.1016/S2213-2600(19)30282-6
- Roe J, Venturini C, Gupta RK, Gurry C, Chain BM, Sun Y, et al. Blood transcriptomic stratification of short-term risk in contacts of tuberculosis. Clin Infect Dis 2020;70:731-7. https://doi.org/10.1093/cid/ciz252
- Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Kimbung Mbandi S, Borate B, et al. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial. Lancet Infect Dis 2021;21:354-65. https://doi.org/10.1016/S1473-3099(20)30914-2
- Mendelsohn SC, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Mbandi SK, Borate B, et al. Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study. Lancet Glob Health 2021;9:e841-53. https://doi.org/10.1016/S2214-109X(21)00045-0
- Sutherland JS, van der Spuy G, Gindeh A, Thuong NT, Namuganga A, Owolabi O, et al. Diagnostic accuracy of the cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results. Clin Infect Dis 2022;74:2136-41. https://doi.org/10.1093/cid/ciab839
- Singhania A, Wilkinson RJ, Rodrigue M, Haldar P, O'Garra A. The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis. Nat Immunol 2018;19:1159-68. https://doi.org/10.1038/s41590-018-0225-9
- Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, et al. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. Lancet Infect Dis 2018;18:1077-87. https://doi.org/10.1016/S1473-3099(18)30355-4
- Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, et al. Risk assessment of tuberculosis in contacts by IFN-γ release assays: a Tuberculosis Network European Trials Group study. Am J Respir Crit Care Med 2015;191:1176-84. https://doi.org/10.1164/rccm.201502-0232OC
- Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012;142:63-75. https://doi.org/10.1378/chest.11-3157
- Sumner T, Scriba TJ, Penn-Nicholson A, Hatherill M, White RG. Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy. Sci Rep 2019;9:11126.
- Gliddon HD, Herberg JA, Levin M, Kaforou M. Genome-wide host RNA signatures of infectious diseases: discovery and clinical translation. Immunology 2018;153:171-8. https://doi.org/10.1111/imm.12841
- Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7. https://doi.org/10.1126/science.286.5439.531
- Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol 2010;8:84.
- Casamassimi A, Federico A, Rienzo M, Esposito S, Ciccodicola A. Transcriptome profiling in human diseases: new advances and perspectives. Int J Mol Sci 2017;18:1652.
- Blankley S, Berry MP, Graham CM, Bloom CI, Lipman M, O'Garra A. The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Philos Trans R Soc Lond B Biol Sci 2014;369:20130427.
- Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466:973-7. https://doi.org/10.1038/nature09247
- Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis 2018;18:e199-210. https://doi.org/10.1016/S1473-3099(18)30111-7
- Hamada Y, Penn-Nicholson A, Krishnan S, Cirillo DM, Matteelli A, Wyss R, et al. Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? A review of evidence and the technological landscape. EBioMedicine 2022;82:104174.
- Anderson ST, Kaforou M, Brent AJ, Wright VJ, Banwell CM, Chagaluka G, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014;370:1712-23. https://doi.org/10.1056/NEJMoa1303657
- Sweeney TE, Braviak L, Tato CM, Khatri P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med 2016;4:213-24. https://doi.org/10.1016/S2213-2600(16)00048-5
- Mendelsohn SC, Mbandi SK, Fiore - Gartland A , Penn-Nicholson A, Musvosvi M, Mulenga H, et al. Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR. Commun Med (Lond) 2022;2:26.